Equillium, Inc. Common Stock

EQNASDAQ • USD
ThemeBiotech - Drug Development›Immunology & Autoimmune
2.99 USD
↗ 0.24 (8.73%)AT CLOSE (11:59 AM EDT)
2.94
↘ 0.06 (1.84%)
POST MARKET (AS OF 07:52 PM EDT)
Post Market
AS OF 07:52 PM EDT
2.94
↘ 0.06 (1.84%)
🔴Market: CLOSED

Equillium, Inc. Common Stock (EQ) is currently trading at $2.97. Technicals currently rate "Strong Buy" while our fundamental analysis reads "Neutral". Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation metrics place EQ at a fair price relative to peers.

Technical & fundamental data as of Jun 17, 2026.

Open?$2.77
High?$3.09
Low?$2.70
Prev. Close?$2.75
Volume?699.6K
Avg. Volume?869.6K
VWAP?$2.96
Rel. Volume?0.80x
Bid / Ask
Bid?$2.71 × 500
Ask?$2.99 × 700
Spread?$0.28
Midpoint?$2.85
Valuation & Ratios
Market Cap?189.0M
Shares Out?63.2M
Float?44.8M
Float %?70.8%
P/E Ratio?N/A
P/B Ratio?3.18
EPS?-$0.30
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydrocarbon receptor, or AhR, modulator, into and through clinical development. The Company operates through a single operating and reportable segment focused on the business of developing novel therapies to treat severe autoimmune and inflammatory disorders, with the mission to develop life-changing therapeutics for patients. The Company manages all business activities on a consolidated basis.
Themes
Biotech - Drug Development›Immunology & Autoimmune
Employees
14
Market Cap
173.9M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.equilliumbio.com
Listed
2018-10-12
Address
2223 AVENIDA DE LA PLAYA
LA JOLLA, CA 92037
Phone: (858) 412-5302
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
77
Short Sent.?
30
Piotroski F-Score?0/9Weak
Altman Z-Score?26.68Safe
Confidence?40%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?8.05%Elevated
Short Interest?3.6M
Days to Cover?6.0
Free Float44.8M
Avg Daily Volume606.6K
Settlement Date2026-05-29
Financial Health
Current Ratio?18.62Strong
Quick Ratio?18.62Strong
Cash Ratio?18.33Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
100
S&P
53
3.18FAIR▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-6.3CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
6
-32.0%WEAK▾
ROA?
S&P
3
-30.2%WEAK▾
Cash Flow & Enterprise
FCF?$-18925000
Enterprise Value?$127.7M
Fundamentals ratios updated end of day
MarketsMoversWatchlist